You are here: Industry Insights > mRNA vaccine

News List

Coriolis Pharma Expands its ATMP Development Facilities b3cnewswire
June 22, 2021
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, today announced the expansion of its ATMP development facilities under biosafety level S2 (BSL2 / S2)
Samsung Biologics Expands Vaccine Manufacturing Capabilities contractpharma
June 02, 2021
Samsung Biologics, a global CDMO providing end-to-end contract development and manufacturing services, unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within ...
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services prnasia
June 01, 2021
Samsung Biologics announced its plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within the earlier part of the year in 2022.
Moderna signs agreement with Gavi to supply COVID-19 vaccine cphi-online
May 24, 2021
Biotech ties up deal three days after World Health Organization issued an emergency use listing for the mRNA vaccine
Biotechs to test feasibility of a shelf-stable, powder mRNA COVID-19 vaccine europeanpharmaceuticalreview
March 11, 2021
The collaborators hope to make mRNA COVID-19 vaccines accessible to all by creating a shelf-stable, reconstitutable powder formulation.
ConserV Bio partners with eTheRNA on mRNA vaccine development pharmatimes
March 05, 2021
London, UK-based ConserV Bioscience has teamed up with eTheRNA immunotherapies to develop mRNA-based vaccines for infectious diseases.
Recovered COVID-19 patients may need only one shot of mRNA vaccines, say scientists expresspharma
February 05, 2021
People who have recovered from the novel coronavirus infection may need only one shot as opposed to the recommended two jabs if they are taking the Moderna or Pfizer COVID-19 vaccines, according to a study which suggests ways to minimise doses when ...
Bayer to manufacture mRNA vaccine in Germany worldpharmanews
February 02, 2021
In a joint press briefing yesterday together with German Health Minister Jens Spahn, Minister-President of North Rhine-Westphalia, Armin Laschet, and Chief Executive Officer of CureVac N.V., Franz-Werner Haas, Member of the Board of Management ...
mRNA COVID-19 vaccine approvals likely to increase development and approvals in oncology: GlobalData expresspharma
February 01, 2021
The rapid advancement of mRNA vaccine development in recent months – in an attempt to halt the COVID-19 pandemic – is expected to continue to break barriers in the pharma industry, with the oncology market being the most likely to benefit, says GlobalData
Gennova’s mRNA vaccine candidate for COVID-19 gets DCGI nod for human clinical trials expresspharma
December 14, 2020
It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of Science & Technology.

Previous page 1 2 3 4 5 Next page